Insider Transactions in Q2 2025 at Kewaunee Scientific Corp (KEQU)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2025
|
Mandar Ranade VP-Information Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,966
+17.52%
|
-
|
Jun 30
2025
|
Ryan S. Noble VP-Sales & Marketing-Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
2,959
+16.68%
|
-
|
Jun 30
2025
|
Donald T. Gardner Iii Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,697
+22.12%
|
-
|
Jun 30
2025
|
Douglas J. Batdorff VP of Manufacturing Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,058
+27.51%
|
-
|
Jun 30
2025
|
Thomas David Hull Iii President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,130
+20.11%
|
-
|
Jun 30
2025
|
Elizabeth D Phillips VP - Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,733
+14.34%
|
-
|
May 07
2025
|
Margaret B Pyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+50.0%
|
-
|
May 07
2025
|
Keith M Gehl Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+8.51%
|
-
|
May 07
2025
|
John Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+5.22%
|
-
|
Apr 14
2025
|
Thomas David Hull Iii President, CEO |
SELL
Open market or private sale
|
Direct |
1,844
-4.86%
|
$59,008
$32.44 P/Share
|
Apr 10
2025
|
Donald T. Gardner Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-6.51%
|
$35,000
$35.18 P/Share
|
Apr 09
2025
|
Donald T. Gardner Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-8.43%
|
$111,000
$37.43 P/Share
|
Apr 04
2025
|
Keith M Gehl Director |
BUY
Open market or private purchase
|
Direct |
1,000
+5.13%
|
$35,000
$35.0 P/Share
|